Company · Woodbridge, Ontario, Canada
Auro Pharma Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 467
- 456 authorized now
- Natural health products
- 10
- 10 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 586
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ACYCLOVIR SODIUM INJECTIONStatus since Oct 2020 | 02494558 | Marketed | |
| AMPICILLIN SODIUM FOR INJECTION BPStatus since Oct 2017 | 02462303 | Marketed | |
| AMPICILLIN SODIUM FOR INJECTION BPStatus since Oct 2017 | 02462311 | Marketed | |
| AMPICILLIN SODIUM FOR INJECTION BPStatus since Oct 2017 | 02462338 | Marketed | |
| AMPICILLIN SODIUM FOR INJECTION BPStatus since Oct 2017 | 02462346 | Marketed | |
| AURO-ABACAVIR/LAMIVUDINEStatus since Aug 2016 | 02454513 | Marketed | |
| AURO-ALENDRONATEStatus since Jul 2012 | 02388545 | Marketed | |
| AURO-ALENDRONATEStatus since Jul 2012 | 02388553 | Marketed | |
| AURO-ALFUZOSINStatus since Sep 2015 | 02443201 | Marketed | |
| AURO-AMLODIPINEStatus since Feb 2013 | 02397072 | Marketed | |
| AURO-AMLODIPINEStatus since Feb 2013 | 02397080 | Marketed | |
| AURO-AMOXICILLINStatus since Jul 2012 | 02388073 | Marketed | |
| AURO-AMOXICILLINStatus since Jul 2012 | 02388081 | Marketed | |
| AURO-AMOXICILLINStatus since Oct 2021 | 02458586 | Marketed | |
| AURO-AMOXICILLINStatus since Oct 2021 | 02458594 | Marketed | |
| AURO-AMOXICLAVStatus since Mar 2022 | 02471671 | Marketed | |
| AURO-AMOXICLAVStatus since Mar 2022 | 02471698 | Marketed | |
| AURO-AMOXICLAVStatus since Mar 2022 | 02471701 | Marketed | |
| AURO-APIXABANStatus since Nov 2022 | 02486806 | Marketed | |
| AURO-APIXABANStatus since Nov 2022 | 02486814 | Marketed | |
| AURO-APREMILASTStatus since Dec 2022 | 02524104 | Marketed | |
| AURO-APREMILASTStatus since Apr 2023 | 02524120 | Marketed | |
| AURO-ARIPIPRAZOLEStatus since Jul 2018 | 02460025 | Marketed | |
| AURO-ARIPIPRAZOLEStatus since Jul 2018 | 02460033 | Marketed | |
| AURO-ARIPIPRAZOLEStatus since Jul 2018 | 02460041 | Marketed | |
| AURO-ARIPIPRAZOLEStatus since Jul 2018 | 02460068 | Marketed | |
| AURO-ARIPIPRAZOLEStatus since Jul 2018 | 02460076 | Marketed | |
| AURO-ARIPIPRAZOLEStatus since Jul 2018 | 02460084 | Marketed | |
| AURO-ATOMOXETINEStatus since Feb 2019 | 02471485 | Marketed | |
| AURO-ATOMOXETINEStatus since Feb 2019 | 02471493 | Marketed | |
| AURO-ATOMOXETINEStatus since Feb 2019 | 02471507 | Marketed | |
| AURO-ATOMOXETINEStatus since Feb 2019 | 02471515 | Marketed | |
| AURO-ATOMOXETINEStatus since Feb 2019 | 02471523 | Marketed | |
| AURO-ATOMOXETINEStatus since Feb 2019 | 02471531 | Marketed | |
| AURO-ATOMOXETINEStatus since Feb 2019 | 02471558 | Marketed | |
| AURO-ATORVASTATINStatus since Apr 2018 | 02407256 | Marketed | |
| AURO-ATORVASTATINStatus since Apr 2018 | 02407264 | Marketed | |
| AURO-ATORVASTATINStatus since Apr 2018 | 02407272 | Marketed | |
| AURO-ATORVASTATINStatus since Apr 2018 | 02407280 | Marketed | |
| AURO-ATOVAQUONEStatus since Mar 2026 | 02556618 | Marketed | |
| AURO-AZILSARTAN MEDOXOMILStatus since Feb 2025 | 02547015 | Marketed | |
| AURO-AZILSARTAN MEDOXOMILStatus since Feb 2025 | 02547023 | Marketed | |
| AURO-AZITHROMYCINStatus since Oct 2019 | 02482363 | Marketed | |
| AURO-AZITHROMYCINStatus since Oct 2019 | 02482371 | Marketed | |
| AURO-BETAHISTINEStatus since Nov 2015 | 02449145 | Marketed | |
| AURO-BETAHISTINEStatus since Nov 2015 | 02449153 | Marketed | |
| AURO-BETAHISTINEStatus since Nov 2015 | 02449161 | Marketed | |
| AURO-BILASTINEStatus since Oct 2024 | 02541556 | Marketed | |
| AURO-BRIVARACETAMStatus since Sep 2024 | 02539292 | Marketed | |
| AURO-BRIVARACETAMStatus since Sep 2024 | 02539306 | Marketed | |
| AURO-BROMFENACStatus since Aug 2026 | 02540789 | Marketed | |
| AURO-BUSPIRONEStatus since Oct 2020 | 02500213 | Marketed | |
| AURO-CANAGLIFLOZINStatus since Jan 2026 | 02510367 | Marketed | |
| AURO-CANAGLIFLOZINStatus since Jan 2026 | 02510375 | Marketed | |
| AURO-CANDESARTANStatus since Jun 2018 | 02445786 | Marketed | |
| AURO-CANDESARTANStatus since Jun 2018 | 02445794 | Marketed | |
| AURO-CANDESARTANStatus since Feb 2019 | 02445808 | Marketed | |
| AURO-CANDESARTANStatus since Feb 2019 | 02445816 | Marketed | |
| AURO-CANDESARTAN HCTStatus since Mar 2015 | 02421038 | Marketed | |
| AURO-CANDESARTAN HCTStatus since Mar 2015 | 02421046 | Marketed | |
| AURO-CANDESARTAN HCTStatus since Mar 2015 | 02421054 | Marketed | |
| AURO-CARVEDILOLStatus since Feb 2014 | 02418495 | Marketed | |
| AURO-CARVEDILOLStatus since Feb 2014 | 02418509 | Marketed | |
| AURO-CARVEDILOLStatus since Feb 2014 | 02418517 | Marketed | |
| AURO-CARVEDILOLStatus since Feb 2014 | 02418525 | Marketed | |
| AURO-CEFIXIMEStatus since Oct 2014 | 02432773 | Marketed | |
| AURO-CEFIXIMEStatus since Jan 2018 | 02468689 | Marketed | |
| AURO-CEFPROZILStatus since Jan 2019 | 02347253 | Marketed | |
| AURO-CEFPROZILStatus since Mar 2024 | 02347261 | Marketed | |
| AURO-CEFPROZILStatus since Mar 2024 | 02347288 | Marketed | |
| AURO-CEFUROXIMEStatus since Jan 2021 | 02344823 | Marketed | |
| AURO-CEFUROXIMEStatus since Jan 2021 | 02344831 | Marketed | |
| AURO-CELECOXIBStatus since Dec 2015 | 02445670 | Marketed | |
| AURO-CELECOXIBStatus since Dec 2015 | 02445689 | Marketed | |
| AURO-CEPHALEXINStatus since Jul 2018 | 02470578 | Marketed | |
| AURO-CEPHALEXINStatus since Jul 2018 | 02470586 | Marketed | |
| AURO-CEPHALEXINStatus since Jul 2020 | 02497743 | Marketed | |
| AURO-CEPHALEXINStatus since Jul 2020 | 02497751 | Marketed | |
| AURO-CINACALCETStatus since Feb 2019 | 02478900 | Marketed | |
| AURO-CINACALCETStatus since Feb 2019 | 02478919 | Marketed | |
| AURO-CINACALCETStatus since Feb 2019 | 02478943 | Marketed | |
| AURO-CIPROFLOXACINStatus since Jun 2012 | 02381907 | Marketed | |
| AURO-CIPROFLOXACINStatus since Jun 2012 | 02381923 | Marketed | |
| AURO-CITALOPRAMStatus since Nov 2011 | 02275562 | Marketed | |
| AURO-CITALOPRAMStatus since Nov 2011 | 02275570 | Marketed | |
| AURO-CLADRIBINEStatus since Jul 2026 | 02566443 | Marketed | |
| AURO-CLINDAMYCINStatus since Mar 2015 | 02436906 | Marketed | |
| AURO-CLINDAMYCINStatus since Mar 2015 | 02436914 | Marketed | |
| AURO-CLOPIDOGRELStatus since Feb 2014 | 02416387 | Marketed | |
| AURO-CYCLOBENZAPRINEStatus since Jun 2011 | 02348853 | Marketed | |
| AURO-DAPAGLIFLOZINStatus since May 2023 | 02531402 | Marketed | |
| AURO-DAPAGLIFLOZINStatus since May 2023 | 02531410 | Marketed | |
| AURO-DAPAGLIFLOZIN / METFORMINStatus since May 2023 | 02533073 | Marketed | |
| AURO-DAPAGLIFLOZIN / METFORMINStatus since May 2023 | 02533081 | Marketed | |
| AURO-DARUNAVIRStatus since Mar 2020 | 02486121 | Marketed | |
| AURO-DARUNAVIRStatus since Mar 2020 | 02486148 | Marketed | |
| AURO-DEFERASIROX (TYPE J)Status since Aug 2024 | 02527774 | Marketed | |
| AURO-DEFERASIROX (TYPE J)Status since Aug 2024 | 02527782 | Marketed | |
| AURO-DEFERASIROX (TYPE J)Status since Aug 2024 | 02527790 | Marketed | |
| AURO-DIGOXINStatus since Jul 2025 | 02554399 | Marketed | |
| AURO-DIGOXINStatus since Jul 2025 | 02554402 | Marketed | |
| AURO-DIMETHYL FUMARATEStatus since Jun 2024 | 02540746 | Marketed | |
| AURO-DIMETHYL FUMARATEStatus since Jun 2024 | 02540754 | Marketed | |
| AURO-DONEPEZILStatus since Dec 2013 | 02400561 | Marketed | |
| AURO-DONEPEZILStatus since Dec 2013 | 02400588 | Marketed | |
| AURO-DULOXETINEStatus since May 2016 | 02436647 | Marketed | |
| AURO-DULOXETINEStatus since May 2016 | 02436655 | Marketed | |
| AURO-DUTASTERIDEStatus since Jun 2018 | 02469308 | Marketed | |
| AURO-EFAVIRENZStatus since Mar 2014 | 02418428 | Marketed | |
| AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIRStatus since Mar 2020 | 02478404 | Marketed | |
| AURO-ELETRIPTANStatus since Feb 2019 | 02479451 | Marketed | |
| AURO-ELETRIPTANStatus since Feb 2019 | 02479478 | Marketed | |
| AURO-EMTRICITABINE-TENOFOVIRStatus since Mar 2023 | 02490684 | Marketed | |
| AURO-ENTECAVIRStatus since Dec 2015 | 02448777 | Marketed | |
| AURO-ENZALUTAMIDEStatus since Mar 2026 | 02494736 | Marketed | |
| AURO-ESCITALOPRAMStatus since Sep 2014 | 02397358 | Marketed | |
| AURO-ESCITALOPRAMStatus since Sep 2014 | 02397374 | Marketed | |
| AURO-ESLICARBAZEPINEStatus since May 2025 | 02527421 | Marketed | |
| AURO-ESLICARBAZEPINEStatus since May 2025 | 02527448 | Marketed | |
| AURO-ESLICARBAZEPINEStatus since May 2025 | 02527456 | Marketed | |
| AURO-ESLICARBAZEPINEStatus since May 2025 | 02527464 | Marketed | |
| AURO-EZETIMIBEStatus since Apr 2018 | 02469286 | Marketed | |
| AURO-FEBUXOSTATStatus since May 2023 | 02533243 | Marketed | |
| AURO-FINASTERIDEStatus since May 2013 | 02405814 | Marketed | |
| AURO-FINASTERIDE 1MGStatus since Nov 2014 | 02428148 | Marketed | |
| AURO-FLECAINIDEStatus since Feb 2017 | 02459957 | Marketed | |
| AURO-FLECAINIDEStatus since Feb 2017 | 02459965 | Marketed | |
| AURO-FLUOXETINEStatus since Jul 2012 | 02385627 | Marketed | |
| AURO-FLUOXETINEStatus since Jul 2012 | 02385635 | Marketed | |
| AURO-GABAPENTINStatus since Jun 2011 | 02321203 | Marketed | |
| AURO-GABAPENTINStatus since Jun 2011 | 02321211 | Marketed | |
| AURO-GABAPENTINStatus since Jun 2011 | 02321238 | Marketed | |
| AURO-GABAPENTIN TABLETSStatus since Jan 2019 | 02428334 | Marketed | |
| AURO-GABAPENTIN TABLETSStatus since Jan 2019 | 02428342 | Marketed | |
| AURO-GALANTAMINE ERStatus since Jun 2014 | 02425157 | Marketed | |
| AURO-GALANTAMINE ERStatus since Jun 2014 | 02425165 | Marketed | |
| AURO-GALANTAMINE ERStatus since Jun 2014 | 02425173 | Marketed | |
| AURO-HYDROCORTISONEStatus since Nov 2022 | 02524465 | Marketed | |
| AURO-HYDROCORTISONEStatus since Nov 2022 | 02524473 | Marketed | |
| AURO-INDOMETHACINStatus since Jul 2021 | 02499223 | Marketed | |
| AURO-LACOSAMIDEStatus since Oct 2018 | 02475332 | Marketed | |
| AURO-LACOSAMIDEStatus since Oct 2018 | 02475340 | Marketed | |
| AURO-LACOSAMIDEStatus since Oct 2018 | 02475359 | Marketed | |
| AURO-LACOSAMIDEStatus since Oct 2018 | 02475367 | Marketed | |
| AURO-LAMIVUDINE/ZIDOVUDINEStatus since Mar 2014 | 02414414 | Marketed | |
| AURO-LAMOTRIGINEStatus since Jun 2012 | 02381354 | Marketed | |
| AURO-LAMOTRIGINEStatus since Jun 2012 | 02381362 | Marketed | |
| AURO-LAMOTRIGINEStatus since Jun 2012 | 02381370 | Marketed | |
| AURO-LEVETIRACETAMStatus since Feb 2012 | 02375249 | Marketed | |
| AURO-LEVETIRACETAMStatus since Mar 2012 | 02375257 | Marketed | |
| AURO-LEVETIRACETAMStatus since Feb 2012 | 02375265 | Marketed | |
| AURO-LEVOCARBStatus since Apr 2023 | 02531593 | Marketed | |
| AURO-LEVOCARBStatus since Apr 2023 | 02531607 | Marketed | |
| AURO-LEVOCARBStatus since Apr 2023 | 02531615 | Marketed | |
| AURO-LIOTHYRONINEStatus since Sep 2025 | 02549999 | Marketed | |
| AURO-LIOTHYRONINEStatus since Sep 2025 | 02550008 | Marketed | |
| AURO-LISINOPRILStatus since Feb 2013 | 02394472 | Marketed | |
| AURO-LISINOPRILStatus since Feb 2013 | 02394480 | Marketed | |
| AURO-LISINOPRILStatus since Feb 2013 | 02394499 | Marketed | |
| AURO-LOSARTANStatus since Mar 2013 | 02403323 | Marketed | |
| AURO-LOSARTANStatus since Mar 2013 | 02403331 | Marketed | |
| AURO-LOSARTANStatus since Mar 2013 | 02403358 | Marketed | |
| AURO-LOSARTAN HCTStatus since Apr 2014 | 02423642 | Marketed | |
| AURO-LOSARTAN HCTStatus since Apr 2014 | 02423650 | Marketed | |
| AURO-LOSARTAN HCTStatus since Apr 2014 | 02423669 | Marketed | |
| AURO-LURASIDONEStatus since Oct 2023 | 02513986 | Marketed | |
| AURO-LURASIDONEStatus since Oct 2023 | 02513994 | Marketed | |
| AURO-LURASIDONEStatus since Oct 2023 | 02514001 | Marketed | |
| AURO-LURASIDONEStatus since Oct 2023 | 02514028 | Marketed | |
| AURO-LURASIDONEStatus since Oct 2023 | 02514036 | Marketed | |
| AURO-MELOXICAMStatus since Oct 2012 | 02390884 | Marketed | |
| AURO-MELOXICAMStatus since Oct 2012 | 02390892 | Marketed | |
| AURO-METFORMINStatus since Feb 2017 | 02438275 | Marketed | |
| AURO-METFORMINStatus since Feb 2017 | 02438283 | Marketed | |
| AURO-METHOTREXATEStatus since Feb 2023 | 02524023 | Marketed | |
| AURO-METRONIDAZOLEStatus since Apr 2018 | 02470284 | Marketed | |
| AURO-MIRABEGRONStatus since Jun 2026 | 02564955 | Marketed | |
| AURO-MIRTAZAPINEStatus since Oct 2013 | 02411695 | Marketed | |
| AURO-MIRTAZAPINEStatus since Oct 2013 | 02411709 | Marketed | |
| AURO-MIRTAZAPINEStatus since Oct 2013 | 02411717 | Marketed | |
| AURO-MIRTAZAPINE ODStatus since Dec 2010 | 02299801 | Marketed | |
| AURO-MIRTAZAPINE ODStatus since Dec 2010 | 02299828 | Marketed | |
| AURO-MIRTAZAPINE ODStatus since Dec 2010 | 02299836 | Marketed | |
| AURO-MODAFINILStatus since Oct 2014 | 02430487 | Marketed | |
| AURO-MONTELUKASTStatus since Mar 2013 | 02401274 | Marketed | |
| AURO-MONTELUKAST CHEWABLE TABLETStatus since May 2022 | 02422867 | Marketed | |
| AURO-MONTELUKAST CHEWABLE TABLETStatus since May 2022 | 02422875 | Marketed | |
| AURO-MOXIFLOXACINStatus since Nov 2015 | 02432242 | Marketed | |
| AURO-NEVIRAPINEStatus since Nov 2020 | 02318601 | Marketed | |
| AURO-NINTEDANIBStatus since Dec 2025 | 02526891 | Marketed | |
| AURO-NINTEDANIBStatus since Dec 2025 | 02526905 | Marketed | |
| AURO-NITROFURANTOIN BIDStatus since Sep 2020 | 02466392 | Marketed | |
| AURO-OLANZAPINE ODTStatus since Dec 2015 | 02448726 | Marketed | |
| AURO-OLANZAPINE ODTStatus since Dec 2015 | 02448734 | Marketed | |
| AURO-OLANZAPINE ODTStatus since Dec 2015 | 02448742 | Marketed | |
| AURO-OLANZAPINE ODTStatus since Dec 2015 | 02448750 | Marketed | |
| AURO-OLMESARTANStatus since May 2017 | 02443864 | Marketed | |
| AURO-OLMESARTANStatus since May 2017 | 02443872 | Marketed | |
| AURO-OLMESARTAN HCTZStatus since Jan 2019 | 02476487 | Marketed | |
| AURO-OLMESARTAN HCTZStatus since Jan 2019 | 02476495 | Marketed | |
| AURO-OLMESARTAN HCTZStatus since Jan 2019 | 02476509 | Marketed | |
| AURO-ONDANSETRON INJECTIONStatus since Oct 2021 | 02491524 | Marketed | |
| AURO-ONDANSETRON INJECTIONStatus since Jul 2021 | 02491532 | Marketed | |
| AURO-ONDANSETRON ODTStatus since Dec 2021 | 02511282 | Marketed | |
| AURO-ONDANSETRON ODTStatus since Dec 2021 | 02511290 | Marketed | |
| AURO-PANTOPRAZOLEStatus since Feb 2016 | 02415208 | Marketed | |
| AURO-PAROXETINEStatus since Jul 2012 | 02383276 | Marketed | |
| AURO-PAROXETINEStatus since Jul 2012 | 02383284 | Marketed | |
| AURO-PAROXETINEStatus since Jul 2012 | 02383292 | Marketed | |
| AURO-PAZOPANIBStatus since Jan 2026 | 02552957 | Marketed | |
| AURO-PERINDOPRILStatus since Mar 2018 | 02459817 | Marketed | |
| AURO-PERINDOPRILStatus since Mar 2018 | 02459825 | Marketed | |
| AURO-PERINDOPRILStatus since Mar 2018 | 02459833 | Marketed | |
| AURO-PIRFENIDONEStatus since Mar 2024 | 02537753 | Marketed | |
| AURO-PIRFENIDONEStatus since Mar 2024 | 02537761 | Marketed | |
| AURO-PRAMIPEXOLEStatus since Apr 2014 | 02424061 | Marketed | |
| AURO-PRAMIPEXOLEStatus since Apr 2014 | 02424088 | Marketed | |
| AURO-PRAMIPEXOLEStatus since Apr 2014 | 02424096 | Marketed | |
| AURO-PRAMIPEXOLEStatus since Apr 2014 | 02424118 | Marketed | |
| AURO-PRAVASTATINStatus since May 2018 | 02458977 | Marketed | |
| AURO-PRAVASTATINStatus since May 2018 | 02458985 | Marketed | |
| AURO-PRAVASTATINStatus since May 2018 | 02458993 | Marketed | |
| AURO-PREGABALINStatus since Mar 2015 | 02433869 | Marketed | |
| AURO-PREGABALINStatus since Mar 2015 | 02433877 | Marketed | |
| AURO-PREGABALINStatus since Mar 2015 | 02433885 | Marketed | |
| AURO-PREGABALINStatus since Mar 2015 | 02433907 | Marketed | |
| AURO-PROGESTERONEStatus since Mar 2020 | 02493578 | Marketed | |
| AURO-QUETIAPINEStatus since Oct 2012 | 02390205 | Marketed | |
| AURO-QUETIAPINEStatus since Oct 2012 | 02390213 | Marketed | |
| AURO-QUETIAPINEStatus since Oct 2012 | 02390248 | Marketed | |
| AURO-QUETIAPINEStatus since Oct 2012 | 02390256 | Marketed | |
| AURO-QUINAPRIL HCTZStatus since Feb 2019 | 02473291 | Marketed | |
| AURO-QUINAPRIL HCTZStatus since Feb 2019 | 02473305 | Marketed | |
| AURO-QUINAPRIL HCTZStatus since Feb 2019 | 02473321 | Marketed | |
| AURO-RAMIPRILStatus since Sep 2012 | 02387387 | Marketed | |
| AURO-RAMIPRILStatus since Sep 2012 | 02387395 | Marketed | |
| AURO-RAMIPRILStatus since Sep 2012 | 02387409 | Marketed | |
| AURO-RAMIPRILStatus since Sep 2012 | 02387417 | Marketed | |
| AURO-REPAGLINIDEStatus since Apr 2014 | 02424258 | Marketed | |
| AURO-REPAGLINIDEStatus since Apr 2014 | 02424266 | Marketed | |
| AURO-REPAGLINIDEStatus since Apr 2014 | 02424274 | Marketed | |
| AURO-RISEDRONATEStatus since Jul 2013 | 02406306 | Marketed | |
| AURO-RITONAVIRStatus since Sep 2022 | 02523620 | Marketed | |
| AURO-RIVAROXABANStatus since Aug 2026 | 02560356 | Marketed | |
| AURO-RIVAROXABANStatus since Aug 2026 | 02560364 | Marketed | |
| AURO-RIVAROXABANStatus since Sep 2026 | 02560372 | Marketed | |
| AURO-ROSUVASTATINStatus since Nov 2015 | 02442574 | Marketed | |
| AURO-ROSUVASTATINStatus since Nov 2015 | 02442582 | Marketed | |
| AURO-ROSUVASTATINStatus since Nov 2015 | 02442590 | Marketed | |
| AURO-ROSUVASTATINStatus since Nov 2015 | 02442604 | Marketed | |
| AURO-RUFINAMIDEStatus since Jul 2024 | 02545985 | Marketed | |
| AURO-RUFINAMIDEStatus since Jul 2024 | 02545993 | Marketed | |
| AURO-SERTRALINEStatus since Oct 2012 | 02390906 | Marketed | |
| AURO-SERTRALINEStatus since Oct 2012 | 02390914 | Marketed | |
| AURO-SERTRALINEStatus since Oct 2012 | 02390922 | Marketed | |
| AURO-SILDENAFILStatus since May 2019 | 02414368 | Marketed | |
| AURO-SILDENAFILStatus since May 2019 | 02414376 | Marketed | |
| AURO-SILDENAFILStatus since May 2019 | 02414384 | Marketed | |
| AURO-SILODOSINStatus since Feb 2022 | 02478501 | Marketed | |
| AURO-SILODOSINStatus since Feb 2022 | 02478528 | Marketed | |
| AURO-SIMVASTATINStatus since Jul 2013 | 02405148 | Marketed | |
| AURO-SIMVASTATINStatus since Jul 2013 | 02405172 | Marketed | |
| AURO-SIMVASTATINStatus since Jul 2013 | 02405156 | Marketed | |
| AURO-SIMVASTATINStatus since Jul 2013 | 02405164 | Marketed | |
| AURO-SIMVASTATINStatus since Jul 2013 | 02405180 | Marketed | |
| AURO-SITAGLIPTINStatus since Jan 2023 | 02529866 | Marketed | |
| AURO-SITAGLIPTINStatus since Jan 2023 | 02529874 | Marketed | |
| AURO-SITAGLIPTINStatus since Jan 2023 | 02529882 | Marketed | |
| AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEStatus since Jul 2025 | 02547805 | Marketed | |
| AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEStatus since Jul 2025 | 02547813 | Marketed | |
| AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEStatus since Jul 2025 | 02547821 | Marketed | |
| AURO-SOLIFENACINStatus since Jan 2016 | 02446375 | Marketed | |
| AURO-SOLIFENACINStatus since Jan 2016 | 02446383 | Marketed | |
| AURO-SUNITINIBStatus since Sep 2023 | 02532190 | Marketed | |
| AURO-SUNITINIBStatus since Jul 2023 | 02532204 | Marketed | |
| AURO-SUNITINIBStatus since Jul 2023 | 02532220 | Marketed | |
| AURO-TADALAFILStatus since Jul 2016 | 02435896 | Marketed | |
| AURO-TADALAFILStatus since Jul 2016 | 02435926 | Marketed | |
| AURO-TADALAFILStatus since Jul 2016 | 02435934 | Marketed | |
| AURO-TADALAFILStatus since Jul 2016 | 02435942 | Marketed | |
| AURO-TAMSULOSIN CRStatus since Aug 2024 | 02545179 | Marketed | |
| AURO-TELMISARTANStatus since Apr 2016 | 02453568 | Marketed | |
| AURO-TELMISARTANStatus since Apr 2016 | 02453576 | Marketed | |
| AURO-TELMISARTAN HCTZStatus since Aug 2016 | 02456389 | Marketed | |
| AURO-TELMISARTAN HCTZStatus since Aug 2016 | 02456397 | Marketed | |
| AURO-TENOFOVIRStatus since Jul 2017 | 02460173 | Marketed | |
| AURO-TERBINAFINEStatus since May 2011 | 02320134 | Marketed | |
| AURO-TOFACITINIBStatus since Nov 2022 | 02530007 | Marketed | |
| AURO-TOFACITINIBStatus since Nov 2022 | 02530015 | Marketed | |
| AURO-TOPIRAMATEStatus since Mar 2020 | 02345803 | Marketed | |
| AURO-TOPIRAMATEStatus since Mar 2020 | 02345838 | Marketed | |
| AURO-TOPIRAMATEStatus since Mar 2020 | 02345846 | Marketed | |
| AURO-TRAMADOLStatus since Apr 2019 | 02479672 | Marketed | |
| AURO-TRAMADOL/ACETAMINOPHENStatus since Apr 2015 | 02439050 | Marketed | |
| AURO-TRANDOLAPRILStatus since Sep 2018 | 02471868 | Marketed | |
| AURO-TRANDOLAPRILStatus since Sep 2018 | 02471876 | Marketed | |
| AURO-TRANDOLAPRILStatus since Sep 2018 | 02471884 | Marketed | |
| AURO-TRANDOLAPRILStatus since Sep 2018 | 02471892 | Marketed | |
| AURO-VALACYCLOVIRStatus since Jul 2015 | 02405040 | Marketed | |
| AURO-VALACYCLOVIRStatus since Jan 2021 | 02405059 | Marketed |
Showing 300 of 467 drug products. For the rest, search Health Canada’s database.
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| Cold-EEZE PlusLicensed Nov 2020 | 80106527 | Active | |
| GeritolLicensed Oct 2020 | 80104841 | Active | |
| MidNite GummiesLicensed Jul 2020 | 80102863 | Active | |
| DONA®Licensed Jan 2020 | 80096645 | Active | |
| Cold-Eeze Plus Defense GummiesLicensed Nov 2019 | 80095267 | Active | |
| MidNite GummiesLicensed Sep 2019 | 80094680 | Active | |
| GeritolLicensed Jun 2016 | 80070040 | Active | |
| VIVARINLicensed Oct 2013 | 80045435 | Active | |
| MidNiteLicensed Nov 2011 | 80028398 | Active | |
| Cold-Eeze®Licensed Aug 2008 | 80007128 | Active |
Notices of Compliance
Newest first.
- AURO-MYCOPHENOLIC ACIDOctober 8, 2026 · NOC 38453 · Abbreviated New Drug Submission (ANDS)
- AURO-ATOVAQUONEOctober 2, 2026 · NOC 38402 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-HYDROXYCHLOROQUINEOctober 1, 2026 · NOC 38394 · Abbreviated New Drug Submission (ANDS)
- AURO-RIVASTIGMINESeptember 24, 2026 · NOC 38355 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MELPHALAN FOR INJECTIONSeptember 16, 2026 · NOC 38294 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-CARBAMAZEPINESeptember 3, 2026 · NOC 38236 · Abbreviated New Drug Submission (ANDS)
- VORICONAZOLE FOR INJECTIONAugust 27, 2026 · NOC 38175 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-METHOTREXATE TABLETSJuly 28, 2026 · NOC 37999 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-BETAHISTINEJuly 24, 2026 · NOC 37983 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ROSUVASTATINJuly 24, 2026 · NOC 37990 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-METFORMINJuly 21, 2026 · NOC 37951 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-DULOXETINEJuly 20, 2026 · NOC 37949 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-DULOXETINEJuly 17, 2026 · NOC 37927 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-AMBRISENTANJuly 16, 2026 · NOC 37925 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-VORICONAZOLEJuly 13, 2026 · NOC 37902 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-DAPAGLIFLOZINJuly 10, 2026 · NOC 37889 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-DAPAGLIFLOZIN / METFORMINJuly 6, 2026 · NOC 37844 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-PERINDOPRIL/INDAPAMIDEJune 30, 2026 · NOC 37817 · Abbreviated New Drug Submission (ANDS)
- AURO-CLONIDINEJune 24, 2026 · NOC 37759 · Abbreviated New Drug Submission (ANDS)
- AURO-BRIVARACETAMMay 28, 2026 · NOC 37643 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-CITALOPRAMMay 21, 2026 · NOC 37585 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-CEPHALEXINMay 6, 2026 · NOC 37484 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-BOSENTANApril 29, 2026 · NOC 37436 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-FLECAINIDEApril 21, 2026 · NOC 38125 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ENZALUTAMIDEMarch 30, 2026 · NOC 37207 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ENZALUTAMIDEMarch 30, 2026 · NOC 37210 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ENZALUTAMIDEMarch 30, 2026 · NOC 37212 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ENZALUTAMIDEMarch 30, 2026 · NOC 37213 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ENZALUTAMIDEMarch 30, 2026 · NOC 37214 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ENZALUTAMIDEMarch 30, 2026 · NOC 37215 · Abbreviated New Drug Submission (ANDS)
- AURO-ENZALUTAMIDEMarch 30, 2026 · NOC 37216 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ELETRIPTANMarch 25, 2026 · NOC 37183 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-TOFACITINIBMarch 18, 2026 · NOC 37135 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-PROGESTERONEMarch 5, 2026 · NOC 37041 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-CLADRIBINEMarch 5, 2026 · NOC 37051 · Abbreviated New Drug Submission (ANDS)
- AURO-IRBESARTAN HCTMarch 4, 2026 · NOC 37039 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-DEFERASIROX (TYPE J)February 27, 2026 · NOC 37000 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-AZILSARTAN MEDOXOMILFebruary 20, 2026 · NOC 36943 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-TOPIRAMATEFebruary 19, 2026 · NOC 36933 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ATORVASTATINFebruary 14, 2026 · NOC 36926 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-CELECOXIBFebruary 4, 2026 · NOC 36843 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IRINOTECAN HYDROCHLORIDE INJECTIONFebruary 2, 2026 · NOC 36820 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-MIRABEGRONJanuary 29, 2026 · NOC 36801 · Abbreviated New Drug Submission (ANDS)
- AURO-METHOTREXATE TABLETSJanuary 9, 2026 · NOC 36704 · Abbreviated New Drug Submission (ANDS)
- AURO-FINASTERIDEJanuary 7, 2026 · NOC 36692 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-LORAZEPAMJanuary 5, 2026 · NOC 36680 · Abbreviated New Drug Submission (ANDS)
- AURO-PAZOPANIBJanuary 2, 2026 · NOC 36664 · Abbreviated New Drug Submission (ANDS)
- AURO-CANAGLIFLOZINJanuary 2, 2026 · NOC 36669 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-CANAGLIFLOZINJanuary 2, 2026 · NOC 36673 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-CANAGLIFLOZINJanuary 2, 2026 · NOC 36678 · Abbreviated New Drug Submission (ANDS)
- AURO-NINTEDANIBDecember 29, 2025 · NOC 36642 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MELPHALAN FOR INJECTIONDecember 23, 2025 · NOC 36623 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ACYCLOVIR SODIUM INJECTIONDecember 18, 2025 · NOC 36583 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-CLOZAPINEDecember 16, 2025 · NOC 36564 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-DULOXETINEDecember 15, 2025 · NOC 36549 · Supplement to an Abbreviated New Drug Submission (SANDS)
- VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USPDecember 15, 2025 · NOC 36551 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ZIPRASIDONEDecember 12, 2025 · NOC 36533 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-BUSPIRONEDecember 11, 2025 · NOC 36525 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-GABAPENTIN; AURO-GABAPENTIN TABLETSDecember 11, 2025 · NOC 36528 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-FAMOTIDINE 10 MG; AURO-FAMOTIDINE 20 MG; AURO-FAMOTIDINE MINT 20 MGDecember 10, 2025 · NOC 36513 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-PREGABALINNovember 28, 2025 · NOC 36453 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-FLECAINIDENovember 26, 2025 · NOC 36433 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-LACOSAMIDENovember 11, 2025 · NOC 36370 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-METHOTREXATEOctober 16, 2025 · NOC 36184 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-AZITHROMYCINOctober 16, 2025 · NOC 36191 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-CANDESARTANSeptember 17, 2025 · NOC 36013 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-LAMOTRIGINESeptember 11, 2025 · NOC 35989 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PANTOPRAZOLE FOR INJECTIONSeptember 5, 2025 · NOC 35968 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-FLUOXETINESeptember 5, 2025 · NOC 35969 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-APIXABANAugust 15, 2025 · NOC 35845 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-RIVAROXABANAugust 14, 2025 · NOC 35838 · Abbreviated New Drug Submission (ANDS)
- AURO-BRIVARACETAMAugust 11, 2025 · NOC 35818 · Supplement to an Abbreviated New Drug Submission (SANDS)
- VORICONAZOLE FOR INJECTIONAugust 11, 2025 · NOC 35858 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-VORICONAZOLEAugust 5, 2025 · NOC 35809 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-RITONAVIRAugust 5, 2025 · NOC 35812 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-DONEPEZILJuly 15, 2025 · NOC 35669 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-LEVOCARBJuly 8, 2025 · NOC 35629 · Supplement to a New Drug Submission (SNDS)
- AURO-DAPAGLIFLOZIN / METFORMINJune 27, 2025 · NOC 35610 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-TERBINAFINEJune 19, 2025 · NOC 35538 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-CARVEDILOLJune 3, 2025 · NOC 35468 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-AMOXICILLINMay 30, 2025 · NOC 35452 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-DESMOPRESSINMay 30, 2025 · NOC 35469 · Abbreviated New Drug Submission (ANDS)
- IBUPROFEN CAPSULES 200 MGMay 23, 2025 · NOC 35421 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ESLICARBAZEPINEMay 7, 2025 · NOC 35312 · Abbreviated New Drug Submission (ANDS)
- AURO-TELMISARTAN HCTZMay 7, 2025 · NOC 35339 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ROSUVASTATINApril 29, 2025 · NOC 35255 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-DAPAGLIFLOZINApril 11, 2025 · NOC 35196 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTIONApril 8, 2025 · NOC 35155 · Supplement to an Abbreviated New Drug Submission (SANDS)
- KETOROLAC TROMETHAMINE INJECTION, USPApril 8, 2025 · NOC 35160 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-ATOVAQUONEApril 1, 2025 · NOC 35108 · Abbreviated New Drug Submission (ANDS)
- AURO-AZILSARTAN MEDOXOMILFebruary 25, 2025 · NOC 34898 · Abbreviated New Drug Submission (ANDS)
- AURO-IRBESARTANFebruary 25, 2025 · NOC 36981 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-EZETIMIBEFebruary 18, 2025 · NOC 34858 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IBUPROFEN CAPSULES 200 MGFebruary 12, 2025 · NOC 34832 · Abbreviated New Drug Submission (ANDS)
- AURO-NITROFURANTOIN BIDFebruary 6, 2025 · NOC 34796 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-RISEDRONATEJanuary 24, 2025 · NOC 34741 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-BOSENTANJanuary 24, 2025 · NOC 34747 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AURO-VARENICLINEJanuary 14, 2025 · NOC 34676 · Abbreviated New Drug Submission (ANDS)
- AURO-DIGOXINJanuary 10, 2025 · NOC 34671 · Abbreviated New Drug Submission (ANDS)
- AURO-AMOXICLAVJanuary 7, 2025 · NOC 34644 · Supplement to an Abbreviated New Drug Submission (SANDS)
The latest 100 of 586.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Auro-Canagliflozin: Affected lots are labelled with the incorrect DIN found on the blister card.March 31, 2026 · Drugs · Product safety · Type III
- Auro-Losartan Product Recall (2021-05-27)May 27, 2021 · Drugs · Product safety · Type I
- Auro-Irbesartan HCT Tablet (2019-04-17)April 17, 2019 · Drugs · Product safety · Type I